Turning Microbial AhR Agonists into Therapeutic Agents via Drug Delivery Systems
Developing therapeutics for inflammatory diseases is challenging due to physiological mucosal barriers, systemic side effects, and the local microbiota. In the search for novel methods to overcome some of these problems, drug delivery systems that improve tissue-targeted drug delivery and modulate t...
Saved in:
Main Authors: | Matteo Puccetti (Author), Marilena Pariano (Author), Paulina Wojtylo (Author), Aurélie Schoubben (Author), Stefano Giovagnoli (Author), Maurizio Ricci (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmaceutically Active Microbial AhR Agonists as Innovative Biodrugs in Inflammation
by: Matteo Puccetti, et al.
Published: (2022) -
Biologics, theranostics, and personalized medicine in drug delivery systems
by: Matteo Puccetti, et al.
Published: (2024) -
Strategies and delivery systems for cell-based therapy in autoimmunity
by: Matteo Puccetti, et al.
Published: (2024) -
The Coevolution of IDO1 and AhR in the Emergence of Regulatory T Cells in Mammals
by: Ursula Grohmann
Published: (2016) -
AhR transcriptional activity in serum of Inuits across Greenlandic districts
by: Bonefeld-Jorgensen Eva C, et al.
Published: (2007)